Johnson & Johnson (JNJ)
S&P 500 Gains and Losses Today: Johnson & Johnson Drops as Judge Rejects Liability Settlement
Major U.S. equities indexes finished the first trading day of the second quarter mixed.
Why Johnson & Johnson Stock Is Sinking Today
Shares of Johnson & Johnson (JNJ -6.57%) are tumbling on Tuesday. The company's stock lost 6.3% as of 2:25 p.m.
Johnson & Johnson shares fall as US judge rejects $10B talc settlement plan
Johnson & Johnson (NYSE:JNJ) shares moved almost 5% lower after a US bankruptcy judge rejected its $10 billion settlement proposal which sought to resolve tens of thousands of lawsuits alleging its talc-based products caused ovarian cancer. Judge Christopher Lopez of the US Bankruptcy Court for the Southern District of Texas, Houston, dismissed the bankruptcy claim filed by J&J subsidiary Red River Talc, citing flaws in the voting process for personal injury claimants.
Judge rejects Johnson & Johnson's $10B settlement to end baby powder lawsuits
A judge rejected Johnson & Johnson's $10 billion proposal to end tens of thousands of lawsuits alleging that its products caused ovarian cancer.
J&J's Third Bankruptcy Attempt to End Talc Suits Rejected
J&J fails in its third attempt to settle tens of thousands of lawsuits claiming its talc-based powder caused cancer.
J&J Dives After Judge Tosses Out $10 Billion Talc-Based Bankruptcy Plan
Johnson & Johnson stock slumped Tuesday after a judge rejected its $10 billion proposal to settle thousands of talc-tied lawsuits. The post J&J Dives After Judge Tosses Out $10 Billion Talc-Based Bankruptcy Plan appeared first on Investor's Business Daily.
Johnson & Johnson Latest Talc Resolution Rejected. The Stock Is Falling.
A bankruptcy judge in Texas rejected a proposal that would have ended most lawsuits saying the products cause ovarian cancer.
J&J shares fall after judge rejects $10 billion talc settlement
Johnson & Johnson shares fell more than 3% on Tuesday after a U.S. bankruptcy judge rejected its $10 billion proposal to end tens of thousands of lawsuits alleging that its baby powder and other talc products cause ovarian cancer.
US judge rejects J&J's $10 billion baby powder settlement
A U.S. bankruptcy judge on Monday rejected Johnson & Johnson's $10 billion proposal to end lawsuits alleging that its baby powder and other talc products cause ovarian cancer, marking the third time the company's bankruptcy strategy has failed in court.
US judge rejects J&J's $10 billion baby powder settlement
A U.S. bankruptcy judge on Monday rejected Johnson & Johnson's $10 billion proposal to end lawsuits alleging that its baby powder and other talc products cause ovarian cancer, marking the third time the company's bankruptcy strategy has failed in court.
Why Johnson & Johnson (JNJ), United Health (UNH) And Procter & Gamble (PG) Are Holding the S&P 500 From Dropping More
As President Trump's April 2nd “Liberation Day” approaches, the stock market has been selling off due to uncertainties on the impact of the tariff policy implementation intended to even out the presently skewed international playing field.
Are You Looking for a High-Growth Dividend Stock?
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Johnson & Johnson (JNJ) have what it takes?
